Nelson PT, Dickson DW, Trojanowski JQ, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503–27 (Important paper from a consensus panel that establishes recommendations for diagnosing LATE.).
PubMed PubMed Central Article Google Scholar
Besser LM, Teylan MA, Nelson PT. Limbic predominant age-related TDP-43 encephalopathy (LATE): clinical and neuropathological associations. J Neuropathol Exp Neurol. 2020;79(3):305–13.
CAS PubMed Article Google Scholar
Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–3 (One of the first studies to discover TDP-43 pathology in neurodegenerative diseases, including FTLD and ALS.).
CAS PubMed Article Google Scholar
Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602–11 (One of the first studies to discover TDP-43 pathology in neurodegenerative diseases, including FTLD and ALS.).
CAS PubMed Article Google Scholar
Amador-Ortiz C, Lin W-L, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol. 2007;61(5):435–45 (First study to find TDP-43 inclusions in hippocampal sclerosis and AD.).
CAS PubMed PubMed Central Article Google Scholar
Nelson PT, Brayne C, Flanagan ME, et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts. Acta Neuropathol. 2022;144(1):27–44 (Updated study determining prevalence of LATE in older adults.).
CAS PubMed Article Google Scholar
Jack CR, Bennett DA, Blennow K, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62.
PubMed PubMed Central Article Google Scholar
Meneses A, Koga S, O’Leary J, Dickson DW, Bu G, Zhao N. TDP-43 Pathology in Alzheimer’s disease. Mol Neurodegen. 2021;16:84.
Thomas DX, Bajaj S, McRae-McKee K, Hadjichrsanthou C, Anderson RM, Collinge J. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer’s disease neuropathology. Sci Rep. 2020;10:14579.
CAS PubMed PubMed Central Article Google Scholar
Robinson JL, Lee EB, Xie SX, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141(7):2181–93.
PubMed PubMed Central Article Google Scholar
Dickson DW, Davies P, Bevona C, et al. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or =80 years of age) humans. Acta Neuropathol. 1994;88:212–21 (First pathological study to define hippocampal sclerosis, a common neuroanatomical feature in LATE.).
CAS PubMed Article Google Scholar
Mehta P, Kaye W, Raymond J, et al. Prevalence of amyotrophic lateral sclerosis — United States, 2015. MMWR Morb Mortal Wkly Rep. 2018;67:1285–9.
PubMed PubMed Central Article Google Scholar
Onyike CU, Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int Rev Psychiatry. 2013;25(2):130–7.
PubMed PubMed Central Article Google Scholar
Lopez OL, Kofler J, Chang YF, et al. Hippocampal sclerosis, TDP-43, and the duration of the symptoms of dementia of AD patients. Ann Clin Transl Neurol. 2020;7(9):1546–56.
CAS PubMed PubMed Central Article Google Scholar
Josephs KA, Dickson DW, Tosakulwong N, et al. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer’s disease: a longitudinal retrospective study. Lancet Neurol. 2017;16(11):917–24.
PubMed PubMed Central Article Google Scholar
Kapasi A, Yu L, Boyle PA, Barnes LL, Bennett DA, Schneider JA. Limbic-predominant age-related TDP-43 encephalopathy (LATE), ADNC pathology, and cognitive decline in aging. Neurology. 2020;95(14):e1951–62 (Recent study on the influence of LATE and AD pathologies on cognitive decline rates.).
CAS PubMed PubMed Central Article Google Scholar
Gauthreaux KM, Teylan MA, Katsumata Y, et al. Limbic-predominant age-related TDP-43 encephalopathy: medical and pathologic factors associated with comorbid hippocampal sclerosis. Neurology. 2022;98(14):e1422–33 (Important study dissecting the differences in clinical and pathological factors affecting LATE with HS vs. LATE without HS.).
CAS PubMed Article Google Scholar
Wilson RS, Yu L, Trojanowski JQ, et al. TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013;70(11):1418–24.
Josephs KA, Murray ME, Whitwell JL, et al. Staging TDP-43 pathology in Alzheimer’s disease. Acta Neuropathol. 2014;127(3):441–50.
CAS PubMed Article Google Scholar
Nag S, Yu L, Boyle PA, Leurgans SE, Bennett DA, Schneider JA. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease. Acta Neuropathol Commun. 2018;6:33.
PubMed PubMed Central Article Google Scholar
Liu KY, Reeves S, McAleese KE, Attems J, Francis P, Thomas A, Howard R. Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease. Brain. 143(12):3842–3849. Important investigation on neurological and psychiatric symptoms in LATE and AD.
Blass DM, Hatanpaa KJ, Rao V, Steinberg M, Troncoso JC, Rabins PV. Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease. Neurology. 2004;63(3):492–7.
CAS PubMed Article Google Scholar
Jo M, Lee S, Jeon YM, Kim S, Kwon Y, Kim HJ. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med. 2020;52(10):1652–62.
CAS PubMed PubMed Central Article Google Scholar
Cohen TJ, Lee VM-Y, Trojanowski TJ. TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies. Trends Mol Med. 2011;17(11):659–667.
Colombrita C, Zennaro E, Fallini C, et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem. 2009;111(4):1051–61.
CAS PubMed Article Google Scholar
McGurk L, Gomes E, Guo L, et al. Poly(ADP-ribose) prevents pathological phase separation of TDP-43 by promoting liquid demixing and stress granule localization. Mol Cell. 2018;71(5):703–17.
CAS PubMed PubMed Central Article Google Scholar
Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci. 2010;30(2):639–49.
CAS PubMed PubMed Central Article Google Scholar
Herzog JJ, Xu W, Deshpande M, et al. TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression. Proc Natl Acad Sci USA. 2020;117(21):11760–9.
CAS PubMed PubMed Central Article Google Scholar
Paolicelli RC, Jawaid A, Henstridge CM, et al. TDP-43 Depletion in microglia promotes amyloid clearance but also induces synapse loss. Neuron. 2017;95:293–308.
James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain. 2016;139(11):2983–93.
PubMed PubMed Central Article Google Scholar
Porta S, Xu Y, Lehr T, et al. Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo. Neuropathol Appl Neurobiol. 2021;47(7):1033–49.
CAS PubMed Article Google Scholar
Tan RH, Ke YD, Ittner LM, Halliday GM. ALS/FTLD: experimental models and reality. Acta Neuropathol. 2017;133(2):177–96.
CAS PubMed Article Google Scholar
de Boer EMJ, Orie VK, Williams T, et al. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry. 2021;92:86–95.
Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet. 2017;26(R2):R105–13.
CAS PubMed Article Google Scholar
Robinson JL, Porta S, Garrett FG, et al. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain. 2020;143(9):2844–57.
PubMed PubMed Central Article Google Scholar
Wider C, Dickson DW, Stoessl AJ, et al. Pallidonigral TDP-43 pathology in Perry syndrome. Parkinsonism Relat Disord. 2009;15(4):281–6.
Dickson DW, Baker M, Rademakers R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegenerative Dis. 2010;7:170–4 (One of the first inquiries into genetic risk for hippocampal sclerosis.).
Mackenzie IRA, Rademakers R. The role of TDP-43 in amyotrophic lateral sclerosis and frontotemporal dementia. Curr Opin Neurol. 2008;21(6):693–700.
留言 (0)